CAD 0.01
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.01 CAD | 23.2% |
2022 | -0.02 CAD | -4.02% |
2021 | -0.02 CAD | 8.9% |
2020 | -0.02 CAD | 18.72% |
2019 | -0.02 CAD | -389.58% |
2018 | -0.00 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.00 CAD | 5.56% |
2024 Q1 | -0.00 CAD | 28.0% |
2023 Q4 | -0.00 CAD | 16.67% |
2023 FY | - CAD | 23.2% |
2023 Q1 | -0.00 CAD | 52.63% |
2023 Q3 | -0.00 CAD | 38.78% |
2023 Q2 | -0.00 CAD | -36.11% |
2022 Q2 | -0.00 CAD | -17.24% |
2022 FY | - CAD | -4.02% |
2022 Q4 | -0.01 CAD | -94.87% |
2022 Q3 | -0.00 CAD | -14.71% |
2022 Q1 | -0.00 CAD | 49.12% |
2021 FY | - CAD | 8.9% |
2021 Q2 | -0.00 CAD | 10.26% |
2021 Q1 | -0.00 CAD | 38.1% |
2021 Q3 | -0.00 CAD | -22.86% |
2021 Q4 | -0.01 CAD | -32.56% |
2020 FY | - CAD | 18.72% |
2020 Q1 | 0.00 CAD | 103.23% |
2020 Q3 | -0.00 CAD | -4.26% |
2020 Q2 | -0.00 CAD | -4800.0% |
2020 Q4 | -0.01 CAD | -28.57% |
2019 Q4 | -0.00 CAD | 81.55% |
2019 Q3 | -0.02 CAD | -1020.0% |
2019 Q1 | -0.00 CAD | -20.0% |
2019 FY | - CAD | -389.58% |
2019 Q2 | -0.00 CAD | -25.0% |
2018 Q3 | -0.00 CAD | -87.5% |
2018 FY | - CAD | 0.0% |
2018 Q4 | -0.00 CAD | 33.33% |
2018 Q2 | -0.00 CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Aquarius Surgical Technologies Inc. | -0.03 CAD | 49.455% |
Cannabix Technologies Inc. | -0.03 CAD | 49.27% |